Dr. Joseph Mercola - Take Control of Your Health Gardasil on Trial: Questioning the Cervical Cancer Vaccine
Apr 14, 2025
The podcast dives into the controversies surrounding the Gardasil vaccine, questioning its effectiveness in preventing cervical cancer. Experts express concern over the lack of long-term studies and the emergence of other HPV strains. There are alarming reports of severe side effects, including heart issues and even fatalities. The discussion highlights the importance of regular pap smears as a critical tool in cervical cancer prevention, while also addressing issues of trust and transparency regarding Merck's marketing practices.
AI Snips
Chapters
Transcript
Episode notes
Gardasil Reduces Lesions, Not Cancer
- Gardasil shows reduction mainly in precancerous lesions, not confirmed cervical cancer cases.
- Cancers can be prevented by screening, highlighting the vaccine's debated cancer-prevention claim.
Pap Smears' Pre-Vaccine Impact
- Pap smears drastically lowered cervical cancer rates before Gardasil's introduction.
- Gardasil targets specific HPV strains, possibly allowing other strains to emerge and offset benefits.
Teen's Death Linked to Vaccine
- Joel Gomez, a healthy 14-year-old, died in his sleep after his second Gardasil shot.
- An investigation suggested heart inflammation triggered by the vaccine as a possible cause.